Mechanisms of Cancer-induced Bone Pain

Coleman, 2006, Clinical features of metastatic bone disease and risk of skeletal morbidity, Clin Cancer Res, 12, 6243s, 10.1158/1078-0432.CCR-06-0931

Nielsen, 1991, Bone metastases: pathophysiology and management policy, J Clin Oncol, 9, 509, 10.1200/JCO.1991.9.3.509

Grond, 1996, Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service, Pain, 64, 107, 10.1016/0304-3959(95)00076-3

Portenoy, 1999, Management of cancer pain, Lancet, 353, 1695, 10.1016/S0140-6736(99)01310-0

Twycross, 1982, Pain in far-advanced cancer, Pain, 14, 303, 10.1016/0304-3959(82)90137-3

Banning, 1991, Pain causes in 200 patients referred to a multidisciplinary cancer pain clinic, Pain, 45, 45, 10.1016/0304-3959(91)90163-R

Coleman, 1997, Skeletal complications of malignancy, Cancer, 80, 1588, 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G

Neville-Webbe, 2003, The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia, Palliat Med, 17, 539, 10.1191/0269216303pm800ra

Rustoen, 2005, Predictors of quality of life in oncology outpatients with pain from bone metastasis, J Pain Symptom Manage, 30, 234, 10.1016/j.jpainsymman.2005.04.002

Mercadante, 1997, Malignant bone pain: pathophysiology and treatment, Pain, 69, 1, 10.1016/S0304-3959(96)03267-8

Oster, 1978, Pain of terminal cancer patients, Arch Intern Med, 138, 1801, 10.1001/archinte.138.12.1801

Portenoy, 2004, Difficult pain problems: an integrated approach, 438

Colvin, 2008, Challenges in cancer pain management-bone pain, Eur J Cancer, 44, 1083, 10.1016/j.ejca.2008.03.001

Mercadante, 1998, Breakthrough pain in cancer patients: pathophysiology and treatment, Cancer Treat Rev, 24, 425, 10.1016/S0305-7372(98)90005-6

Laird, 2009

de Wit, 2001, The Amsterdam Pain Management Index compared to eight frequently used outcome measures to evaluate the adequacy of pain treatment in cancer patients with chronic pain, Pain, 91, 339, 10.1016/S0304-3959(00)00455-3

Meuser, 2001, Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology, Pain, 93, 247, 10.1016/S0304-3959(01)00324-4

Chow, 2007, Meta-analysis of palliative radiotherapy trials for bone metastases, Clin Oncol (R Coll Radiol), 19

McQuay, 2000, Radiotherapy for the palliation of painful bone metastases, Cochrane Database Syst Rev

Bailey, 2006, Oral opioid drugs, 43

Portenoy, 1999, Breakthrough pain: characteristics and impact in patients with cancer pain, Pain, 81, 129, 10.1016/S0304-3959(99)00006-8

Urch, 2004, The pathophysiology of cancer-induced bone pain: current understanding, Palliat Med, 18, 267, 10.1191/0269216304pm887ra

Michaelson, 2005, Bisphosphonates for treatment and prevention of bone metastases, J Clin Oncol, 23, 8219, 10.1200/JCO.2005.02.9579

Wong, 2002, Bisphosphonates for the relief of pain secondary to bone metastases, Cochrane Database Syst Rev, 10.1002/14651858.CD002068

Seibel, 2005, Clinical use of markers of bone turnover in metastatic bone disease, Nat Clin Pract Oncol, 2, 504, 10.1038/ncponc0320

Garnero, 2000, Markers of bone turnover for the management of patients with bone metastases from prostate cancer, Br J Cancer, 82, 858, 10.1054/bjoc.1999.1012

Clohisy, 1996, Localized, tumor-associated osteolysis involves the recruitment and activation of osteoclasts, J Orthop Res, 14, 2, 10.1002/jor.1100140103

Schwei, 1999, Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain, J Neurosci, 19, 10886, 10.1523/JNEUROSCI.19-24-10886.1999

Blair, 2006, Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis, Nat Clin Pract Oncol, 3, 41, 10.1038/ncponc0381

Honore, 2000, Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord, Nat Med, 6, 521, 10.1038/74999

Luger, 2001, Osteoprotegerin diminishes advanced bone cancer pain, Cancer Res, 61, 4038

Mundy, 1997, Mechanisms of bone metastasis, Cancer, 80, 1546, 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I

Body, 2003, A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases, Cancer, 97, 887, 10.1002/cncr.11138

Sabino, 2002, The involvement of prostaglandins in tumorigenesis, tumor-induced osteolysis and bone cancer pain, J Musculoskelet Neuronal Interact, 2, 561

Payne, 1997, Mechanisms and management of bone pain, Cancer, 80, 1608, 10.1002/(SICI)1097-0142(19971015)80:8+<1608::AID-CNCR11>3.0.CO;2-3

Sabino, 2002, Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2, Cancer Res, 62, 7343

Sevcik, 2005, Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization, Pain, 115, 128, 10.1016/j.pain.2005.02.022

Lassiter, 2003, Endothelin receptor antagonists in the treatment of prostate cancer, Semin Oncol, 30, 678, 10.1016/S0093-7754(03)00353-1

Vega, 2003, Neurotrophins and the immune system, J Anat, 203, 1, 10.1046/j.1469-7580.2003.00203.x

Sabino, 2005, Pathophysiology of bone cancer pain, J Support Oncol, 3, 15

Donovan-Rodriguez, 2005, Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain, Anesthesiology, 102, 132, 10.1097/00000542-200501000-00022

Luger, 2002, Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain, Pain, 99, 397, 10.1016/S0304-3959(02)00102-1

Honore, 2000, Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons, Neuroscience, 98, 585, 10.1016/S0306-4522(00)00110-X

Urch, 2003, Alterations in dorsal horn neurones in a rat model of cancer-induced bone pain, Pain, 106, 347, 10.1016/j.pain.2003.08.002

Martin, 2007, Organization of a unique net-like meshwork of CGRP+ sensory fibers in the mouse periosteum: implications for the generation and maintenance of bone fracture pain, Neurosci Lett, 427, 148, 10.1016/j.neulet.2007.08.055

Mach, 2002, Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur, Neuroscience, 113, 155, 10.1016/S0306-4522(02)00165-3

Urch, 2005, Efficacy of chronic morphine in a rat model of cancer-induced bone pain: behavior and in dorsal horn pathophysiology, J Pain, 6, 837

Matthews, 2002, A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy, Anesthesiology, 96, 633, 10.1097/00000542-200203000-00020

Honore, 2000, Cellular and neurochemical remodeling of the spinal cord in bone cancer pain, Prog Brain Res, 129, 389, 10.1016/S0079-6123(00)29030-4

Mantyh, 1995, Rapid endocytosis of a G protein-coupled receptor: substance P evoked internalization of its receptor in the rat striatum in vivo, Proc Natl Acad Sci USA, 92, 2622, 10.1073/pnas.92.7.2622

Mantyh, 1995, Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation, Science, 268, 1629, 10.1126/science.7539937

Fukamachi, 2001, Altered expressions of glutamate transporter subtypes in rat model of neonatal cerebral hypoxia-ischemia, Brain Res Dev Brain Res, 132, 131, 10.1016/S0165-3806(01)00303-0

Rothstein, 1992, Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis, N Engl J Med, 326, 1464, 10.1056/NEJM199205283262204

Gordon-Williams, 2007, Central neuronal mechanisms in cancer-induced bone pain, Curr Opin Support Palliat Care, 1, 6, 10.1097/SPC.0b013e328133f5e9

Suzuki, 2002, Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways, Nat Neurosci, 5, 1319, 10.1038/nn966

Donovan-Rodriguez, 2006, Evidence of a role for descending serotonergic facilitation in a rat model of cancer-induced bone pain, Neurosci Lett, 393, 237, 10.1016/j.neulet.2005.09.073